P1185: A PROSPECTIVE SINGLE-CENTER PHASE 2 STUDY OF ZANUBRUTINIB PLUS R-CHOP IN TREAT-NAÏVE INTRAVASCULAR LARGE B CELL LYMPHOMA

HemaSphere (Aug 2023)

Affiliations

Yan Zhang: 1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China
Chao Chen: 1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China
Danqing Zhao: 1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China
Zhe Zhuang: 1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China
Chong Wei: 1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China
Wei Wang: 1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China
Wei Zhang: 1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China
Dao-Bin Zhou: 1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China

Abstract

No abstracts available.

ISSN: 2572-9241 (Online)
Publisher: Wiley
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: http://www.hemaspherejournal.com